Stuart Barnscher
Senior Director, Preclinical Programs, ADC Therapeutic Development Zymeworks
Seminars
Wednesday 5th November 2025
Spotlighting Development & Therapeutic Potential of ZW327: Targeting Ly6E
12:00 pm
- Exploring target characteristics and solid tumor expression rationale for re-exploring Ly6E
- Showcasing design and development of ZW327 across anti-Ly6E antibody generation and novel Topo1 payload
- Exploring preliminary finding sand future development plans for ZW327 across solid tumors
